About: Guidelines for balancing priorities in structural heart disease during the COVID-19 pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Guidelines for balancing priorities in structural heart disease during the COVID-19 pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Guidelines for balancing priorities in structural heart disease during the COVID-19 pandemic
Creator	Waksman, Ron Bch, B Case, Brian Chezar-Azerrad, Chava Forrestal, Brian Khalid, Nauman Khan, Jaffar Musallam, Anees Rogers, Toby Shlofmitz, Evan Yerasi, Charan Chava Chezar-Azerrad, ;
source	Elsevier; Medline; PMC
abstract	During the novel coronavirus disease 2019 (COVID-19) pandemic, many hospitals have been asked to postpone elective and surgical cases. This begs the question, “What is elective in structural heart disease intervention?” The recently proposed Society for Cardiovascular Angiography and Interventions/American College of Cardiology consensus statement is, unfortunately, non-specific and insufficient in its scope and scale of response to the COVID-19 pandemic. We propose guidelines that are practical, multidisciplinary, implementable, and urgent. We believe that this will provide a helpful framework for our colleagues to manage their practice during the surge and peak phases of the pandemic. General principles that apply across structural heart disease interventions include tracking and reporting cardiovascular outcomes, “healthcare distancing,” preserving vital resources and personnel, shared decision-making between the heart team and hospital administration on resource-intensive cases, and considering delaying research cases. Specific guidance for transcatheter aortic valve replacement and MitraClip procedures varies according to pandemic phase. During the surge phase, treatment should broadly be limited to those at increased risk of complications in the near term. During the peak phase, treatment should be limited to inpatients for whom it may facilitate discharge. Keeping our patients and ourselves safe is paramount, as well as justly rationing resources.
has issue date	2020-05-30(xsd:dateTime)
bibo:doi	10.1016/j.carrev.2020.05.040
bibo:pmid	32736981
has license	no-cc
sha1sum (hex)	ec6b6d4db29297f4082f17f019d40ab8b4b1a80a
schema:url	https://doi.org/10.1016/j.carrev.2020.05.040
resource representing a document's title	Guidelines for balancing priorities in structural heart disease during the COVID-19 pandemic
has PubMed Central identifier	PMC7261108
has PubMed identifier	32736981
schema:publication	Cardiovasc Revasc Med
resource representing a document's body	covid:ec6b6d4db29297f4082f17f019d40ab8b4b1a80a#body_text
is schema:about of	named entity 'COVID-19' named entity 'Balancing' named entity 'Structural Heart Disease' named entity 'COVID-19 Pandemic' named entity 'TAVR' named entity 'aortic stenosis' named entity 'TAVR' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'Ontario' named entity 'heart disease' named entity 'heart failure' named entity 'MitraClip' named entity 'asymptomatic patients' named entity 'aortic stenosis' named entity 'ventilator' named entity 'prognosis' named entity 'MitraClip' named entity 'MitraClip' named entity 'heart failure' named entity 'heart failure' named entity 'Cardiovascular' named entity 'transesophageal echocardiography' named entity 'echocardiographic' named entity 'transcatheter aortic valve replacement' named entity 'TAVR' named entity 'NYHA' named entity 'mmHg' named entity 'systolic pressure' named entity 'coronavirus disease 2019' named entity 'NYHA class' named entity 'TAVR' named entity 'aortic stenosis' named entity 'aortic stenosis' named entity 'mitral valve repair' named entity 'asymptomatic patients' named entity 'aortic stenosis' named entity 'MitraClip' named entity 'syncope' named entity 'aortic stenosis' named entity 'intensive care unit' named entity 'heart failure' named entity 'American College of Cardiology' named entity 'TAVR' named entity 'TAVR' named entity 'chronic kidney disease' named entity 'mortality rate' named entity 'heart failure' named entity 'TAVR' named entity 'elective surgeries' named entity 'aortic stenosis' named entity 'New York Heart Association' named entity 'aortic stenosis' named entity 'surgical aortic valve replacement' named entity 'COVID' named entity 'United States' named entity 'aortic stenosis' named entity 'resource allocation' named entity 'pulmonary artery' named entity 'ACC' named entity 'TAVR' named entity 'ICU' named entity 'CMS' named entity 'Angiography' named entity 'patient outcomes' named entity 'SARS-CoV-2' named entity 'heart failure' named entity 'aortic stenosis' named entity 'mortality rate' named entity 'virus' named entity 'mitral valve repair'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software